• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHM 基因同义变异导致脉络膜视网膜变性的剪接异常。

Synonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia.

机构信息

,.

出版信息

Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):38. doi: 10.1167/iovs.61.2.38.

DOI:10.1167/iovs.61.2.38
PMID:32097478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7329626/
Abstract

PURPOSE

Choroideremia is an inherited retinal degeneration caused by 280 different pathogenic variants in the CHM gene. Only one silent/synonymous variant (c.1359C>T; p.(Ser453=)) has been reported and was classified as inconclusive based on in silico analysis. This study elucidates the pathogenicity of this variant also found in a Brazilian patient.

METHODS

Ophthalmological examinations such as color fundus photography, spectral-domain optical coherence tomography, fundus autofluorescence, and macular integrity assessment microperimetry were performed. The subjects' total RNA was extracted from peripheral blood cells. cDNA was synthesized and the amplification between exon 10 and 14 of the CHM mRNA was performed. The amplification products were sequenced by Sanger sequencing and the results were aligned to the reference sequence.

RESULTS

The synonymous variant c.1359C>T p.(Ser453=) in the CHM gene is associated with an error in mRNA processing, leading preferentially to production of an aberrant transcript without exon 11 (p.(Gln451Phefs*3)). This anomalous mRNA production is related to typical choroideremia phenotype.

CONCLUSIONS

These molecular findings reinforce the need for more detailed investigation of silent variants in patients with well-defined phenotype of retinal dystrophies. Molecular and clinical findings provided evidence that c.1359C>T (p.(Gln451Phefs*3)) in CHM should be considered a disease-causing variant.

摘要

目的

脉络膜视网膜变性是一种遗传性视网膜疾病,由 CHM 基因中的 280 种不同的致病性变异引起。仅报道了一种沉默/同义变异(c.1359C>T;p.(Ser453=)),根据计算机分析被归类为不确定。本研究阐明了在一名巴西患者中发现的这种变异的致病性。

方法

进行眼科检查,如眼底彩色照相、谱域光相干断层扫描、眼底自发荧光和黄斑完整性评估微视野检查。从外周血血细胞中提取受试者的总 RNA。合成 cDNA,并对 CHM mRNA 的外显子 10 和 14 之间进行扩增。通过 Sanger 测序对扩增产物进行测序,并将结果与参考序列进行比对。

结果

CHM 基因中的同义变异 c.1359C>T p.(Ser453=)与 mRNA 加工错误相关,导致优先产生没有外显子 11 的异常转录本(p.(Gln451Phefs*3))。这种异常 mRNA 的产生与典型的脉络膜视网膜变性表型相关。

结论

这些分子发现加强了在具有明确视网膜营养不良表型的患者中对沉默变异进行更详细调查的必要性。分子和临床发现提供了证据,表明 CHM 中的 c.1359C>T(p.(Gln451Phefs*3))应被视为致病变异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d7d/7329626/48df8cdbb821/iovs-61-2-38-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d7d/7329626/b6ce7d29b108/iovs-61-2-38-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d7d/7329626/757dc796fdf0/iovs-61-2-38-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d7d/7329626/48df8cdbb821/iovs-61-2-38-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d7d/7329626/b6ce7d29b108/iovs-61-2-38-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d7d/7329626/757dc796fdf0/iovs-61-2-38-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d7d/7329626/48df8cdbb821/iovs-61-2-38-f003.jpg

相似文献

1
Synonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia.CHM 基因同义变异导致脉络膜视网膜变性的剪接异常。
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):38. doi: 10.1167/iovs.61.2.38.
2
CHOROIDEREMIA ASSOCIATED WITH A NOVEL SYNONYMOUS MUTATION IN GENE ENCODING REP-1.与编码REP-1的基因中的新型同义突变相关的视网膜色素变性
Retin Cases Brief Rep. 2018;12 Suppl 1(Suppl 1):S67-S71. doi: 10.1097/ICB.0000000000000647.
3
A putative frameshift variant in the CHM gene is associated with an unexpected splicing alteration in a choroideremia patient.CHM 基因的一个假定移码变异与一名脉络膜视网膜炎患者的意外剪接改变有关。
Mol Genet Genomic Med. 2020 Nov;8(11):e1490. doi: 10.1002/mgg3.1490. Epub 2020 Sep 19.
4
Association of Messenger RNA Level With Phenotype in Patients With Choroideremia: Potential Implications for Gene Therapy Dose.《脉络膜视网膜变性患者的信使 RNA 水平与表型的关联:基因治疗剂量的潜在影响》
JAMA Ophthalmol. 2020 Feb 1;138(2):128-135. doi: 10.1001/jamaophthalmol.2019.5071.
5
Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.女性脉络膜视网膜病变携带者的视网膜营养不良和视网膜下类玻璃膜疣沉积物
Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2099-2111. doi: 10.1007/s00417-017-3751-5. Epub 2017 Jul 27.
6
Whole exome sequencing of a family revealed a novel variant in the CHM gene, c.22delG p.(Glu8Serfs*4), which co-segregated with choroideremia.对一个家族的全外显子组测序发现了 CHM 基因中的一个新变异,c.22delG p.(Glu8Serfs*4),该变异与脉络膜视网膜变性共分离。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20200067.
7
Autofluorescence in female carriers with choroideremia: A familial case with a novel mutation in the gene.女性携带者的脉络膜视网膜变性的自发荧光:一个家族病例和一个新的基因突变。
Ophthalmic Genet. 2020 Dec;41(6):625-628. doi: 10.1080/13816810.2020.1810283. Epub 2020 Aug 24.
8
Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation.脉络膜视网膜病变女性携带者长期随访期间视网膜色素上皮改变的进展及一种新的CHM突变报告
Arch Ophthalmol. 2009 Jul;127(7):907-12. doi: 10.1001/archophthalmol.2009.123.
9
Molecular analysis of the choroideremia gene related clinical findings in two families with choroideremia.两个无脉络膜症家族中与无脉络膜症基因相关临床发现的分子分析
Mol Vis. 2011;17:2564-9. Epub 2011 Sep 30.
10
Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.携带新型CHM突变的一个大脉络膜视网膜病变家系的临床特征
Arch Ophthalmol. 2012 Sep;130(9):1184-9. doi: 10.1001/archophthalmol.2012.1117.

引用本文的文献

1
A novel SVA retrotransposon insertion in the gene results in loss of REP-1 causing choroideremia.一个新的 SVA 反转录转座子插入 基因导致 REP-1 缺失,引起脉络膜视网膜变性。
Ophthalmic Genet. 2020 Aug;41(4):341-344. doi: 10.1080/13816810.2020.1768557. Epub 2020 May 22.
2
Whole exome sequencing of a family revealed a novel variant in the CHM gene, c.22delG p.(Glu8Serfs*4), which co-segregated with choroideremia.对一个家族的全外显子组测序发现了 CHM 基因中的一个新变异,c.22delG p.(Glu8Serfs*4),该变异与脉络膜视网膜变性共分离。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20200067.

本文引用的文献

1
Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.脉络膜视网膜变性携带者疾病严重程度和表型谱。
Am J Ophthalmol. 2019 Nov;207:77-86. doi: 10.1016/j.ajo.2019.06.002. Epub 2019 Jun 8.
2
Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments.视网膜色素变性:从基因和临床表型分析到基因治疗及未来疗法
Ther Adv Ophthalmol. 2018 Dec 27;10:2515841418817490. doi: 10.1177/2515841418817490. eCollection 2018 Jan-Dec.
3
Novel CHM mutations in Polish patients with choroideremia - an orphan disease with close perspective of treatment.
波兰罹患脉络膜视网膜变性患者中的新型 CHM 突变——一种具有治疗密切前景的孤儿病。
Orphanet J Rare Dis. 2018 Dec 12;13(1):221. doi: 10.1186/s13023-018-0965-5.
4
Macular spatial distribution of preserved autofluorescence in patients with choroideremia.脉络膜视网膜变性患者黄斑区自发荧光的空间分布。
Br J Ophthalmol. 2019 Jul;103(7):933-937. doi: 10.1136/bjophthalmol-2018-312620. Epub 2018 Oct 8.
5
Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results.脉络膜黑蒙 2 型基因治疗的 2 期临床试验:24 个月的结果。
Am J Ophthalmol. 2019 Jan;197:65-73. doi: 10.1016/j.ajo.2018.09.012. Epub 2018 Sep 19.
6
Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience.AAV2 介导的脉络膜视网膜炎基因治疗两年后的结果:艾伯塔省的经验。
Am J Ophthalmol. 2018 Sep;193:130-142. doi: 10.1016/j.ajo.2018.06.011. Epub 2018 Jun 27.
7
Choroideremia: molecular mechanisms and development of AAV gene therapy.脉络膜视网膜变性:AAV 基因治疗的分子机制和发展。
Expert Opin Biol Ther. 2018 Jul;18(7):807-820. doi: 10.1080/14712598.2018.1484448. Epub 2018 Jun 22.
8
Retinal Degeneration in Choroideremia follows an Exponential Decay Function.脉络膜缺损所致视网膜变性呈指数衰减函数。
Ophthalmology. 2018 Jul;125(7):1122-1124. doi: 10.1016/j.ophtha.2018.02.004. Epub 2018 Mar 23.
9
Novel mutation in the choroideremia gene and multi-Mendelian phenotypes in Spanish families.新型突变致脉络膜视网膜炎基因和西班牙家系中的多种孟德尔表型。
Br J Ophthalmol. 2018 Oct;102(10):1378-1386. doi: 10.1136/bjophthalmol-2017-311427. Epub 2018 Jan 24.
10
Characterizing the Natural History of Visual Function in Choroideremia Using Microperimetry and Multimodal Retinal Imaging.使用微视野计和多模态视网膜成像技术表征脉络膜视网膜病变患者视觉功能的自然病程。
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5575-5583. doi: 10.1167/iovs.17-22486.